American Well Overview
American Well (AMWL) has a ROE of -35.31%, below the Healthcare sector average of 22.01%.
Get informed when a big investor buys or sells
+ Follow-35.31%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
American Well (AMWL) currently reports a ROE of -35.31%. That is below the Healthcare sector average of 22.01%. Use the charts on this page to explore American Well's ROE history and peer comparisons.
American Well's ROE of -35.31% is lower than the Healthcare sector average of 22.01%. That is roughly 260.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but American Well's current -35.31% should be judged against Healthcare norms (sector average: 22.01%) and against AMWL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -35.31%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.01%. From there, open related valuation or income-statement pages for American Well, and consider following AMWL for alerts when major investors trade the stock.
American Well is classified in the Healthcare sector. On ROE, it currently shows -35.31% versus a sector average near 22.01%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMWL with unrelated industries.
